A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

NCT06812494 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

NIH

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: VRC07-523LS 400mg
BIOLOGICAL: PGT121.414.LS 400mg
BIOLOGICAL: PGDM1400LS 400mg
BIOLOGICAL: VRC07-523LS 3200mg
BIOLOGICAL: PGT121.414.LS 1600mg
BIOLOGICAL: PGDM1400LS 1600mg

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]